Value of caveolin-1 in cancer progression and prognosis: Emphasis on cancer-associated fibroblasts, human cancer cells and mechanism of caveolin-1 expression

被引:52
作者
Chen, Dali [1 ]
Che, Guowei [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Thorac Surg, Chengdu 610041, Sichuan, Peoples R China
关键词
caveolin-1; cancer-associated fibroblasts; mechanisms; human cancer cells; cancer progression; EARLY TUMOR RECURRENCE; DISEASE-FREE SURVIVAL; PROSTATE-CANCER; STROMAL CAVEOLIN-1; POOR-PROGNOSIS; OXIDATIVE STRESS; MEMBRANE-BINDING; UP-REGULATION; BASAL-LIKE; FUNCTIONAL-SIGNIFICANCE;
D O I
10.3892/ol.2014.2385
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Caveolin-1 (Cav-1) is found predominately in terminally differentiated cells, such as adipocytes, endothelia and smooth muscle cells, as well as type I pneumocytes. As a main structural component of caveolae, Cav-1 is important in modulating cellular signaling. In the present study, the expression and clinical role of Cav-1 were analyzed in tumor stromal and human cancer cells, respectively. The results of previous studies have shown that the downregulation of tumor stromal Cav-1 promotes tumor survival and predicts a poor tumor prognosis, predominantly concentrating on the mechanism of the metabolism of the cancer microenvironment (according to the autophagic tumor stroma model of cancer metabolism and the reverse Warburg effect). However, contradictory results concerning the expression, clinical roles and associated mechanisms of Cav-1 have been reported. An improved understanding of Cav-1 expression in tumor stromal and cancer cells will increase knowledge with regard to the clinical value of Cav-1 and its detailed mechanisms. This review summarizes the novel data concerning the clinical values and probable mechanisms of Cav-1 expression in tumor stromal (predominantly in cancer-associated fibroblasts) and cancer cells, respectively.
引用
收藏
页码:1409 / 1421
页数:13
相关论文
共 137 条
  • [1] Ando T, 2007, ONCOL REP, V18, P601
  • [2] Membrane binding of peptides containing both basic and aromatic residues.: Experimental studies with peptides corresponding to the scaffolding region of caveolin and the effector region of MARCKS
    Arbuzova, A
    Wang, LB
    Wang, JY
    Hangyás-Mihályné, G
    Murray, D
    Honig, B
    McLaughlin, S
    [J]. BIOCHEMISTRY, 2000, 39 (33) : 10330 - 10339
  • [3] The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk
    Arpaia, E.
    Blaser, H.
    Quintela-Fandino, M.
    Duncan, G.
    Leong, H. S.
    Ablack, A.
    Nambiar, S. C.
    Lind, E. F.
    Silvester, J.
    Fleming, C. K.
    Rufini, A.
    Tusche, M. W.
    Bruestle, A.
    Ohashi, P. S.
    Lewis, J. D.
    Mak, T. W.
    [J]. ONCOGENE, 2012, 31 (07) : 884 - 896
  • [4] Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression
    Ayala, Gustavo
    Morello, Matteo
    Frolov, Anna
    You, Sungyong
    Li, Rile
    Rosati, Fabiana
    Bartolucci, Gianluca
    Danza, Giovanna
    Adam, Rosalyn M.
    Thompson, Timothy C.
    Lisanti, Michael P.
    Freeman, Michael R.
    Di Vizio, Dolores
    [J]. JOURNAL OF PATHOLOGY, 2013, 231 (01) : 77 - 87
  • [5] Caveolin-1 immuno-expression in human gastric cancer: histopathogenetic hypotheses
    Barresi, V.
    Giuffre', G.
    Vitarelli, E.
    Todaro, P.
    Tuccari, G.
    [J]. VIRCHOWS ARCHIV, 2008, 453 (06) : 571 - 578
  • [6] The retinoblastoma protein pathway and the restriction point
    Bartek, J
    Bartkova, J
    Lukas, J
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1996, 8 (06) : 805 - 814
  • [7] p53 regulates caveolin gene transcription, cell cholesterol, and growth by a novel mechanism
    Bist, A
    Fielding, CJ
    Fielding, PE
    [J]. BIOCHEMISTRY, 2000, 39 (08) : 1966 - 1972
  • [8] Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma
    Campbell, L.
    Jasani, B.
    Edwards, K.
    Gumbleton, M.
    Griffiths, D. F. R.
    [J]. BRITISH JOURNAL OF CANCER, 2008, 98 (05) : 931 - 940
  • [9] Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma
    Campbell, L
    Gumbleton, M
    Griffiths, DFR
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (10) : 1909 - 1913
  • [10] Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling
    Cantiani, Lara
    Manara, Maria Cristina
    Zucchini, Cinzia
    De Sanctis, Paola
    Zuntini, Monia
    Valvassori, Luisa
    Serra, Massimo
    Olivero, Martina
    Di Renzo, Maria Flavia
    Colombo, Mario Paolo
    Picci, Piero
    Scotlandi, Katia
    [J]. CANCER RESEARCH, 2007, 67 (16) : 7675 - 7685